Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Lettieri

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|September 23, 2024
Machine Learning in Early Prediction of Metabolism of DrugsMarta Lettieri, Marco Rodda, Virginia Carlucci
Middle East African Journal of Ophthalmology|April 21, 2010
Inflammatory choroidal neovascularizationPiergiorgi Neri, Marta Lettieri, Cinzia Fortuna, et al.
International Ophthalmology|February 3, 2011
Adalimumab (Humira™): a promising monoclonal anti-tumor necrosis factor alpha in ophthalmologyPiergiorgio Neri, Manuela Zucchi, Pia Allegri, et al.
International Ophthalmology|September 4, 2009
Association of systemic steroids and mycophenolate mofetil as rescue therapy for uveitic choroidal neovascularization unresponsive to the traditional immunosuppressants: interventional case seriesPiergiorgio Neri, Mara Manoni, Cinzia Fortuna, et al.
Middle East African Journal of Ophthalmology|December 25, 2010
Adalimumab (humira™) in ophthalmology: a review of the literaturePiergiorgio Neri, Marta Lettieri, Cinzia Fortuna, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|September 23, 2024
Machine Learning in Early Prediction of Metabolism of DrugsMarta Lettieri, Marco Rodda, Virginia Carlucci
Middle East African Journal of Ophthalmology|April 21, 2010
Inflammatory choroidal neovascularizationPiergiorgi Neri, Marta Lettieri, Cinzia Fortuna, et al.
International Ophthalmology|February 3, 2011
Adalimumab (Humira™): a promising monoclonal anti-tumor necrosis factor alpha in ophthalmologyPiergiorgio Neri, Manuela Zucchi, Pia Allegri, et al.
International Ophthalmology|September 4, 2009
Association of systemic steroids and mycophenolate mofetil as rescue therapy for uveitic choroidal neovascularization unresponsive to the traditional immunosuppressants: interventional case seriesPiergiorgio Neri, Mara Manoni, Cinzia Fortuna, et al.
Middle East African Journal of Ophthalmology|December 25, 2010
Adalimumab (humira™) in ophthalmology: a review of the literaturePiergiorgio Neri, Marta Lettieri, Cinzia Fortuna, et al.
Pageof 1